AbbVie, GSK, Merck & Co., and Novo Nordisk Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from AbbVie, GlaxoSmithKline, Merck & Co., and Novo Nordisk.  Editor’s…

GSK Gets New Viiv Healthcare CEO as Current CEO Steps Down
By

By
GlaxoSmithKline (GSK) has appointed Deborah Waterhouse the chief executive officer (CEO) designate of ViiV Healthcare, a specialist human immunodeficiency virus (HIV) company established in November 2009 by GSK and Pfizer…

Novartis, Kite Pharma Plan Regulatory Filings for CAR T Therapies
By

By
Novartis and Kite Pharma, a Santa Monica, California-based clinical-stage biopharmaceutical company, have both announced plans for filing applications seeking regulatory approval for their respective chimeric antigen receptor T-cell (CAR T)…

Amgen, Allergan File Avastin Biosimilar With EMA
By

By
Amgen and Allergan have submitted a marketing authorization application to the European Medicines Agency (EMA) for ABP 215, a biosimilar candidate to Avastin (bevacizumab), Roche’s blockbuster anti-cancer biologic. Avastin is…

AstraZeneca Partners to Develop Bicyclic Peptides in $1 Billion-Deal
By

By
AstraZeneca has formed a collaboration with Bicycle Therapeutics, a Cambridge, UK-headquartered biotechnology company specializing in therapeutics based on its proprietary bicyclic peptide product platform in a deal worth more than…

Takeda to Build $106-Million Vaccine Manufacturing Plant
By

By
Takeda Pharmaceuticals has announced that it will invest more than EUR 100 million ($106 million) to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany. Initial…

Evonik Raises Capacity for Biomaterials
By

By
Evonik has announced that it is expanding its production facilities in Birmingham, Alabama and Darmstadt, Germany that will create additional capacity for the production of biodegradable polymers that are used…

Almac Expands Packaging Facility
By

By
Almac Group, a contract development and manufacturing organization, has expanded its UK commercial packaging facility with the acquisition of a stick sachet packaging line from Merz, a Lich, Germany-headquartered custom…

RoPack to Launch Serialization Hub
By

By
Ropack Pharma Solutions, a Moontreal-based provider of solid oral dosage packaging solutions, plans to launch an international serialization hub for pharmaceutical organizations and contract packaging partners. Through the serialization hub,…

FDA Clears Xellia’s Ohio Operations
By

By
The US Food and Drug Administration (FDA) has notified Xellia Pharmaceuticals, a Copenhagen, Denmark-headquartered specialty pharmaceutical company focused on anti-infective treatments, that it is allowing the company to begin packaging…